Find trials
Search tips

Spectrum And Prevalence Of Kidney Disease In Female Carriers Of CLCN5 And OCRL

Overview

About this study

The purpose of this study is to determine the spectrum and prevalence of kidney disease in CLCN5 female carriers.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Female

  • Part of the Dent Disease Foundation (DDF)

Exclusion Criteria:

  • Participants will not be excluded based on race, ethnicity, or ethnic minority status.

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

 Eligibility last updated 09/03/2026. Questions regarding updates should be directed to the study team contact. 

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

David Sas, D.O.

Contact us for the latest status

Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

Mira Keddis, M.D.

Open for enrollment

More information

Publications

Publications are currently not available

More about research at Mayo Clinic

.
CLS-20610923

Mayo Clinic Footer